Cough as an adverse effect on inhalation pharmaceutical products

Br J Pharmacol. 2020 Sep;177(18):4096-4112. doi: 10.1111/bph.15197. Epub 2020 Aug 7.

Abstract

Cough is an adverse effect that may hinder the delivery of drugs into the lungs. Chemical or mechanical stimulants activate the transient receptor potential in some airway afferent nerves (C-fibres or A-fibres) to trigger cough. Types of inhaler device and drug, dose, excipients and formulation characteristics, including pH, tonicity, aerosol output and particle size may trigger cough by stimulating the cough receptors. Release of inflammatory mediators may increase the sensitivity of the cough receptors to stimulants. The cough-provoking effect of aerosols is enhanced by bronchoconstriction in diseased airways and reduces drug deposition in the target pulmonary regions. In this article, we review the factors by which inhalation products may cause cough.

Keywords: adverse effect; aerosol; cough; inhalation; pharmaceutical products.

Publication types

  • Review

MeSH terms

  • Administration, Inhalation*
  • Aerosols / therapeutic use
  • Bronchoconstriction*
  • Cough* / chemically induced
  • Humans
  • Lung
  • Particle Size

Substances

  • Aerosols